Perceptive Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.6M | Hold |
|
|||||
|
2023
Q3 | $3.58M | Buy |
|
|||||
|
2023
Q2 | $1.39M | Hold |
|
|||||
|
2023
Q1 | $2.04M | Hold |
|
|||||
|
2022
Q4 | $1.91M | Hold |
|
|||||
|
2022
Q3 | $2.24M | Sell |
|
|||||
|
2022
Q2 | $13.8M | Sell |
|
|||||
|
2022
Q1 | $47.6M | Hold |
|
|||||
|
2021
Q4 | $57.3M | Sell |
|
|||||
|
2021
Q3 | $47.7M | Buy |
|
|||||
|
2021
Q2 | $26.9M | Sell |
|
|||||
|
2021
Q1 | $82.4M | Sell |
|
|||||
|
2020
Q4 | $95.2M | Buy |
|
|||||
|
2020
Q3 | $59.8M | Hold |
|
|||||
|
2020
Q2 | $28.9M | Buy |
|
|||||
|
2020
Q1 | $42.2M | Hold |
|
|||||
|
2019
Q4 | $41M | Sell |
|
|||||
|
2019
Q3 | $37.9M | Sell |
|
|||||
|
2019
Q2 | $75.8M | Buy |
|
|||||
|
2019
Q1 | $69.1M | Sell |
|
|||||
|
2018
Q4 | $49.8M | Buy |
|
|||||
|
2018
Q3 | $60.5M | Hold |
|
|||||
|
2018
Q2 | $57.4M | Hold |
|
|||||
|
2018
Q1 | $71.8M | Buy |
|
|||||
|
2017
Q4 | $56.3M | Sell |
|
|||||
|
2017
Q3 | $66.9M | Buy |
|
|||||
|
2017
Q2 | $51.8M | Sell |
|
|||||
|
2017
Q1 | $51.8M | Buy |
|
|||||
|
2016
Q4 | $50.9M | Buy |
|
|||||
|
2016
Q3 | $54.8M | Sell |
|
|||||
|
2016
Q2 | $58.4M | Buy |
|
|||||
|
2016
Q1 | $41M | Buy |
|
|||||
|
2015
Q4 | $49.8M | Sell |
|
|||||
|
2015
Q3 | $53.6M | Sell |
|
|||||
|
2015
Q2 | $91.7M | Buy |
|
|||||
|
2015
Q1 | $66.7M | Buy |
|
|||||
|
2014
Q4 | $23.8M | Buy |
|
|||||
|
2014
Q3 | $12.4M | Buy |
|
|||||
|
2014
Q2 | $15M | Buy |
|
|||||
|
2014
Q1 | $22.1M | Sell |
|
|||||
|
2013
Q4 | $7.37M | Buy |
|